Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02140554 |
|---|---|
| Brief Title: | A Study Evaluating the Safety and Efficacy of the LentiGlobin BB305 Drug Product in Severe Sickle Cell Disease |
| First Submitted : | May 14, 2014 |
| First Submitted that Met QC Criteria : | May 14, 2014 |
| First Posted : | May 16, 2014 (Estimate) |
| Last Update Submitted that Met QC Criteria : | April 17, 2020 |
| Last Update Posted : | April 20, 2020 |